Selected research
Market Structure
Global Topical Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Topical Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Analgesics include Sanofi, Johnson & Johnson, Novartis, Mylan, GSK, Topical BioMedics, THE PURE SOURCE, Teikoku Seiyaku and Qizheng, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Topical Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Topical Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Topical Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.
Topical Analgesics Segment by Company
Sanofi
Johnson & Johnson
Novartis
Mylan
GSK
Topical BioMedics
THE PURE SOURCE
Teikoku Seiyaku
Qizheng
Mercury Healthcare
Lingrui
Huarun 999
Hisamitsu
Endo
Actavis
Topical Analgesics Segment by Type
Pain Relief Patches
Analgesic Creams
Analgesic Sprays
Topical Analgesics Segment by Application
Muscle Pain
Arthritis Pain
Topical Analgesics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Topical Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pain Relief Patches
- Analgesic Creams
- Analgesic Sprays
Applications
- Muscle Pain
- Arthritis Pain
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- GSK
- Topical BioMedics
- THE PURE SOURCE
- Teikoku Seiyaku
- Qizheng
- Mercury Healthcare
- Lingrui
- Huarun 999
- Hisamitsu
- Endo
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Topical Analgesics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Topical Analgesics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Topical Analgesics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Topical Analgesics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Topical Analgesics Market Dynamics
- 2.1 Topical Analgesics Industry Trends
- 2.2 Topical Analgesics Industry Drivers
- 2.3 Topical Analgesics Industry Opportunities and Challenges
- 2.4 Topical Analgesics Industry Restraints
3 Topical Analgesics Market by Manufacturers
- 3.1 Global Topical Analgesics Revenue by Manufacturers (2021-2026)
- 3.2 Global Topical Analgesics Sales by Manufacturers (2021-2026)
- 3.3 Global Topical Analgesics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Topical Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Analgesics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Topical Analgesics Manufacturers, Product Type & Application
- 3.7 Global Topical Analgesics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Topical Analgesics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Topical Analgesics Players Market Share by Revenue in 2025
- 3.8.3 2025 Topical Analgesics Tier 1, Tier 2, and Tier 3
4 Topical Analgesics Market by Type
- 4.1 Topical Analgesics Type Introduction
- 4.1.1 Pain Relief Patches
- 4.1.2 Analgesic Creams
- 4.1.3 Analgesic Sprays
- 4.2 Global Topical Analgesics Sales by Type
- 4.2.1 Global Topical Analgesics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Topical Analgesics Sales by Type (2021-2032)
- 4.2.3 Global Topical Analgesics Sales Market Share by Type (2021-2032)
- 4.3 Global Topical Analgesics Revenue by Type
- 4.3.1 Global Topical Analgesics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Topical Analgesics Revenue by Type (2021-2032)
- 4.3.3 Global Topical Analgesics Revenue Market Share by Type (2021-2032)
5 Topical Analgesics Market by Application
- 5.1 Topical Analgesics Application Introduction
- 5.1.1 Muscle Pain
- 5.1.2 Arthritis Pain
- 5.2 Global Topical Analgesics Sales by Application
- 5.2.1 Global Topical Analgesics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Topical Analgesics Sales by Application (2021-2032)
- 5.2.3 Global Topical Analgesics Sales Market Share by Application (2021-2032)
- 5.3 Global Topical Analgesics Revenue by Application
- 5.3.1 Global Topical Analgesics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Topical Analgesics Revenue by Application (2021-2032)
- 5.3.3 Global Topical Analgesics Revenue Market Share by Application (2021-2032)
6 Global Topical Analgesics Sales by Region
- 6.1 Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Topical Analgesics Sales by Region (2021-2032)
- 6.2.1 Global Topical Analgesics Sales by Region (2021-2026)
- 6.2.2 Global Topical Analgesics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Topical Analgesics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Topical Analgesics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Topical Analgesics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Topical Analgesics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Topical Analgesics Revenue by Region
- 7.1 Global Topical Analgesics Revenue by Region
- 7.1.1 Global Topical Analgesics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Topical Analgesics Revenue by Region (2021-2026)
- 7.1.3 Global Topical Analgesics Revenue by Region (2027-2032)
- 7.1.4 Global Topical Analgesics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Topical Analgesics Revenue (2021-2032)
- 7.2.2 North America Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Topical Analgesics Revenue (2021-2032)
- 7.3.2 Europe Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Topical Analgesics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Topical Analgesics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Topical Analgesics Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Topical Analgesics Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Topical Analgesics Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Mylan
- 8.4.1 Mylan Company Information
- 8.4.2 Mylan Business Overview
- 8.4.3 Mylan Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mylan Topical Analgesics Product Portfolio
- 8.4.5 Mylan Recent Developments
- 8.5 GSK
- 8.5.1 GSK Company Information
- 8.5.2 GSK Business Overview
- 8.5.3 GSK Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 GSK Topical Analgesics Product Portfolio
- 8.5.5 GSK Recent Developments
- 8.6 Topical BioMedics
- 8.6.1 Topical BioMedics Company Information
- 8.6.2 Topical BioMedics Business Overview
- 8.6.3 Topical BioMedics Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Topical BioMedics Topical Analgesics Product Portfolio
- 8.6.5 Topical BioMedics Recent Developments
- 8.7 THE PURE SOURCE
- 8.7.1 THE PURE SOURCE Company Information
- 8.7.2 THE PURE SOURCE Business Overview
- 8.7.3 THE PURE SOURCE Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 THE PURE SOURCE Topical Analgesics Product Portfolio
- 8.7.5 THE PURE SOURCE Recent Developments
- 8.8 Teikoku Seiyaku
- 8.8.1 Teikoku Seiyaku Company Information
- 8.8.2 Teikoku Seiyaku Business Overview
- 8.8.3 Teikoku Seiyaku Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Teikoku Seiyaku Topical Analgesics Product Portfolio
- 8.8.5 Teikoku Seiyaku Recent Developments
- 8.9 Qizheng
- 8.9.1 Qizheng Company Information
- 8.9.2 Qizheng Business Overview
- 8.9.3 Qizheng Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Qizheng Topical Analgesics Product Portfolio
- 8.9.5 Qizheng Recent Developments
- 8.10 Mercury Healthcare
- 8.10.1 Mercury Healthcare Company Information
- 8.10.2 Mercury Healthcare Business Overview
- 8.10.3 Mercury Healthcare Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Mercury Healthcare Topical Analgesics Product Portfolio
- 8.10.5 Mercury Healthcare Recent Developments
- 8.11 Lingrui
- 8.11.1 Lingrui Company Information
- 8.11.2 Lingrui Business Overview
- 8.11.3 Lingrui Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Lingrui Topical Analgesics Product Portfolio
- 8.11.5 Lingrui Recent Developments
- 8.12 Huarun 999
- 8.12.1 Huarun 999 Company Information
- 8.12.2 Huarun 999 Business Overview
- 8.12.3 Huarun 999 Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Huarun 999 Topical Analgesics Product Portfolio
- 8.12.5 Huarun 999 Recent Developments
- 8.13 Hisamitsu
- 8.13.1 Hisamitsu Company Information
- 8.13.2 Hisamitsu Business Overview
- 8.13.3 Hisamitsu Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Hisamitsu Topical Analgesics Product Portfolio
- 8.13.5 Hisamitsu Recent Developments
- 8.14 Endo
- 8.14.1 Endo Company Information
- 8.14.2 Endo Business Overview
- 8.14.3 Endo Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Endo Topical Analgesics Product Portfolio
- 8.14.5 Endo Recent Developments
- 8.15 Actavis
- 8.15.1 Actavis Company Information
- 8.15.2 Actavis Business Overview
- 8.15.3 Actavis Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Actavis Topical Analgesics Product Portfolio
- 8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Topical Analgesics Value Chain Analysis
- 9.1.1 Topical Analgesics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Topical Analgesics Production Mode & Process
- 9.2 Topical Analgesics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Topical Analgesics Distributors
- 9.2.3 Topical Analgesics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst